Synthetic Biology Governance

Introduction

Synthetic Biology Governance refers to the legal, ethical, scientific and institutional framework used to regulate the research, development, production and commercial application of synthetic biological technologies. It aims to balance scientific innovation with human safety, environmental protection, public health and national security.

Synthetic biology involves designing, modifying or constructing biological systems, organisms and genetic materials for specific purposes. Its applications include vaccine development, genetic engineering, disease treatment, agricultural improvement, industrial biotechnology and environmental management.

However, these technologies may create risks such as accidental release of engineered organisms, genetic contamination, misuse of biological research, biodiversity loss and discrimination based on genetic information. Therefore, effective governance requires proper licensing, scientific risk assessment, institutional supervision and legal accountability.

India does not have one independent statute exclusively governing synthetic biology. Instead, its regulatory framework is based on environmental legislation, biotechnology rules, constitutional protections and scientific guidelines.

Legal and Regulatory Framework in India

1. Environment (Protection) Act, 1986: Sections 3, 6 and 8 empower the Central Government to take measures for environmental protection and regulate hazardous substances. This Act provides the statutory foundation for India's biotechnology biosafety framework.

2. Biosafety Rules, 1989: The Rules regulate the manufacture, use, import, export and storage of hazardous microorganisms and genetically engineered organisms or cells. They also extend to relevant new gene technologies.

Wii Government+1

3. Institutional Biosafety Committees (IBSCs): These committees supervise research involving recombinant or synthetic nucleic acid molecules and assess institutional biosafety arrangements.

4. RCGM and GEAC: The Review Committee on Genetic Manipulation (RCGM), functioning under the Department of Biotechnology, monitors relevant research activities. The Genetic Engineering Appraisal Committee (GEAC) performs regulatory appraisal and approval functions, particularly concerning large-scale use and environmental release.

ibkp.dbt.gov.in+1

5. Recombinant DNA Research and Biocontainment Guidelines, 2017: These guidelines establish safety procedures, containment requirements and risk-management practices for relevant biotechnology research.

dbtindia.gov.in+1

Important Case Laws

1. Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential elements of Indian environmental law. These principles require preventive measures where synthetic biological technologies may cause serious environmental damage. They also support the responsibility of biotechnology organisations to remedy pollution caused by their activities.

2. M.C. Mehta v. Union of India (1987) 1 SCC 395

In the Oleum Gas Leak case, the Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities. This principle is relevant by analogy where biotechnology industries cause harm through unsafe handling or accidental release of engineered organisms.

3. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional freedoms. This judgment is relevant to synthetic biology governance because genetic information, DNA records and biological data require protection against unauthorised collection, use and disclosure.

4. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court delivered a split verdict concerning the environmental release of genetically modified mustard. The judgments discussed scientific risk assessment, environmental protection, regulatory transparency and the precautionary principle. This decision is particularly relevant to the governance of emerging biological technologies.

India

Major Principles of Synthetic Biology Governance

Biosafety: Preventing accidental release and harmful biological activities.

Scientific accountability: Ensuring responsible research and independent risk assessment.

Environmental protection: Safeguarding biodiversity and ecological balance.

Human rights: Protecting genetic privacy, bodily autonomy and human dignity.

Regulatory transparency: Ensuring scientifically justified approvals and effective monitoring.

Legal liability: Establishing responsibility and compensation for biological or environmental harm.

Conclusion

Synthetic Biology Governance is an emerging field that combines biotechnology regulation, environmental law, constitutional rights and scientific ethics. Although India does not have a separate comprehensive Synthetic Biology Act, the Environment (Protection) Act, 1986, Biosafety Rules, 1989 and related guidelines provide an important regulatory foundation. Future legislation should establish clearer standards for genetic engineering, biological risk assessment, research supervision, environmental release and corporate accountability. The objective should be to encourage scientific innovation while protecting human health, biodiversity and public welfare.

Note: The cited judgments establish relevant constitutional and environmental principles. None directly decides a comprehensive legal framework for synthetic biology governance.